EQS-NVR: BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Summary by AI ^BETAClose X

BB BIOTECH AG has announced a new total number of voting rights as of June 15, 2026, following an "other (capital) measure." The company now has 55,149,250 voting rights, with no multiple voting rights. This announcement is made in accordance with Article 41 of the German Securities Trading Act (WpHG) and is intended for Europe-wide distribution.

Disclaimer*

EQS Total Voting Rights Announcement: BB BIOTECH AG / Total Voting Rights Announcement
BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

15.06.2026 / 07:00 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Publication of new total number of voting rights according to Sec. 41 WpHG

1. Details of issuer

BB BIOTECH AG
Schwertstrasse 6
8200 Schaffhausen
Switzerland

2. Type of capital measure or other measure

	Type of capital measure or other measure	Date of status / date of effect
	Conditional capital increase (Sec. 41 para. 2 WpHG)
X	Other (capital) measure (Sec. 41 para. 1 WpHG)	15 Jun 2026

3. New total number of voting rights:

55149250
number of multiple voting rights thereof: 0

15.06.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News